Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
A-769662: AMPK Activator Workflow
2026-09-09
A-769662 is a reversible AMPK activator for dissecting energy metabolism, lipid synthesis, autophagy signaling, and proteasome-linked cell-cycle phenotypes. This workflow emphasizes orthogonal readouts so researchers can separate genuine AMPK effects from the compound’s AMPK-independent proteasome activity.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-08
Cy3 Goat Anti-Mouse IgG (H+L) Antibody is a fluorescent mouse IgG detection antibody for visualizing mouse primary antibodies in immunofluorescence, flow cytometry, and western blot workflows. It is intended for research use only; assay-specific dilution, background, sensitivity, and live-cell compatibility should be established experimentally rather than assumed.
-
Plant Cell Lysis Buffer for WB and IP Workflow
2026-09-08
Build cleaner Western blots, native immunoprecipitations, and co-IP assays from challenging plant samples with a non-denaturing detergent-and-inhibitor formulation. This workflow also explains how plant-focused extraction principles can inform mechanistic protein studies without overstating cross-species evidence.
-
NSC-23766 Rac GTPase Inhibitor Workflow
2026-09-07
NSC-23766 enables controlled interrogation of Rac1-dependent cytoskeletal remodeling, barrier integrity, apoptosis, and cancer-cell growth. This guide connects dose-response design with live-cell phagocytosis assays, helping researchers distinguish Rac1-specific effects from broader toxicity or pathway compensation.
-
BIBR 1532: Telomerase Inhibition Workflows
2026-09-07
BIBR 1532 enables mechanism-focused studies that separate immediate hTERT inhibition from later telomere attrition and apoptosis. This workflow guide combines telomerase activity assays, leukemia pathway profiling, and carefully controlled comparisons with DNA-damaging telomere strategies.
-
TRAP-1 Reactivates p53Y220C Through Induced Proximity
2026-09-05
The preprint reports TRAP-1, a mutant-specific chemical inducer of proximity that brings p53Y220C into a functional complex with BRD4 and restores transcriptional activity. In pancreatic cancer cell models, this mechanism rapidly induced p21 and other p53 target genes while suppressing growth, with ternary-complex-defective controls failing to reproduce the response.
-
ERCC1 Deficiency, p53, and Cisplatin Sensitivity
2026-09-04
Heyza and colleagues used CRISPR-Cas9-engineered lung cancer models to show that ERCC1 loss does not produce a uniform platinum response: cisplatin hypersensitivity depends strongly on retained wild-type p53. The study identifies DNA-PKcs and BRCA1-associated repair as potential tolerance mechanisms, refining interpretation of ERCC1 as a biomarker for platinum chemotherapy.
-
TCF25 Links Glucose Starvation to Lysosomal Cell Death
2026-09-04
Ren et al. identify TCF25 as a nutrient-responsive regulator that connects glucose starvation to V-ATPase-dependent lysosomal acidification, autophagy, and eventual lysosome-dependent cell death. The study provides a mechanistic framework for separating early metabolic adaptation from prolonged starvation injury and suggests experimental strategies for studying lysosomal iron handling in ischemic and metabolic disease.
-
Concanamycin A Workflow for V-ATPase Studies
2026-09-03
Build a controlled V-ATPase perturbation workflow around Concanamycin A to connect endosomal pH, trafficking, apoptosis, and invasion phenotypes. This guide combines product-specific dosing benchmarks with a practical framework for separating direct acidification effects from downstream sphingolipid and stress responses.
-
Acridine Orange hydrochloride: Practical Guide
2026-09-03
Acridine Orange hydrochloride provides cell-permeable fluorescent nucleic acid staining with green and red signal behavior that can support DNA and RNA differential staining, cell cycle analysis, and flow-based cytochemical workflows. It should be used as a nucleic-acid dye with assay-specific validation, not as a standalone apoptosis or organelle-function readout, and prepared solutions should not be stored long term.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-09-02
Yin et al. identify a brain-to-spinal μ-opioid receptor circuit that links lateral parabrachial, hypothalamic, and spinal neurons to morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study separates mechanical from thermal opioid effects and provides a circuit framework for testing receptor-specific contributions in neuropharmacology and pain mechanism research.
-
Azithromycin: From Stock Solution to Assay Signal
2026-09-02
Azithromycin is a macrolide antibiotic whose experimental value depends on more than ribosome targeting. This guide connects chemical-stability control, impurity-aware analytics, resistance interpretation, and cross-model assay design.
-
Baicalein: Designing Mechanism-Resolved Assays
2026-09-01
Baicalein is a 12-LOX-focused flavonoid for studying cancer cell proliferation inhibition, apoptosis, and inflammatory signaling. This guide uses a recent chemotherapy-neurotoxicity study to show how mechanism-specific controls and paired models can produce more informative Baicalein data.
-
Neurospora crassa IPA Pathway and Auxin Biosynthesis
2026-09-01
Sardar and Kempken provide the first integrated genetic and biochemical characterization of an indole-3-pyruvic acid pathway for indole-3-acetic acid production in Neurospora crassa. Their knockout and metabolite analyses connect fungal IPA metabolism with auxin production and conidiation, offering a framework for studying fungal–plant chemical interactions.
-
Intravesical p21 mRNA–LNP Therapy for Bladder Cancer
2026-08-31
The reference study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its data connect transient nuclear p21 restoration with cell-cycle suppression, DNA-damage accumulation, apoptosis, and tumor control while limiting systemic exposure in an orthotopic mouse model.